Transaction · 0000874015-25-000079

O'NEIL PATRICK R.

O'NEIL PATRICK R., EC, GC, reported a transaction classified as grant at IONIS PHARMACEUTICALS INC involving 3820.000000 shares for an estimated $0.00. Reported holdings after the transaction were 65023.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code AEC, GC
IONSIONIS PHARMACEUTICALS INC
Filing timeFeb 04
Trade dateJan 30, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

IONS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IONS since 2025-02-04Filed 576 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0000874015-25-000079
Common Stock
Transaction date
Jan 30, 2025
Filed Feb 04, 2025, 12:27 AM · 5d delay
Shares
3.82k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
65.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP CLO & General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares earned upon the vesting of performance-based restricted stock units ("PRSUs") for the final performance period of the grant to the reporting person reported on January 19, 2022. The…

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $32.84 inclusive. The reporting person undertakes to provi…

Original filing · 0000874015-25-000079
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IONS